Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.

Biotechnology

Nucleix

Chris Hibberd

Danny Frumkin

Eli Frydman

John Stillwagen

Mathias Ehrich

Michael G. Vicari

Eran Bram

Todd Myers

Heiner Dreismann

Erez Chimovits

Gerard A. Silvestri

Stephen Lam

Nate Davis

Parker Cassidy

Seth P. Lerner

Peter Mazzone

Mina Gaga

Barton Grossman

Martin C. Tammemägi

John Field

Maria J. Ribal

Thomas Buchholz

Ilan Lior

The Research and Development team at Nucleix is responsible for pioneering innovative cancer diagnostic panels utilizing epigenetic biomarkers. Their work involves cutting-edge research, bioinformatics analysis, and product development to advance the detection and diagnosis of various cancer types. This team, composed of scientists, data scientists, and product development experts, aims to translate scientific discoveries into clinically viable diagnostic tools.

Research and Development

The Advisory Team at Nucleix provides expert guidance and strategic insights to support the development and implementation of the company's cancer diagnostic products. Comprising specialists with vast knowledge in oncology, biomarkers, and diagnostics, the team plays a pivotal role in steering research, regulatory affairs, and market positioning to ensure the success and effectiveness of Nucleix's offerings.

Advisory Team

The Leadership Team at Nucleix is responsible for setting the strategic direction and overseeing the execution of company initiatives aimed at advancing cancer diagnostics. This diverse team, composed of experts in software, medical research, product development, sales, marketing, and finance, collaborates to drive innovation, ensure regulatory compliance, and enhance market reach, all while maintaining a strong focus on improving patient outcomes through epigenetic biomarker technology.

Leadership Team

The Software and IT Team at Nucleix is responsible for developing, maintaining, and optimizing the software solutions that support the company's cutting-edge cancer diagnostic panels. This includes creating sophisticated algorithms for epigenetic biomarker analysis, ensuring data integrity, and providing robust IT infrastructure to facilitate seamless research and development. The team collaborates closely with other departments to integrate their software solutions into Nucleix's product pipeline, thereby advancing the company's mission of improving cancer diagnostics.

Software and IT Team

The Product Development and Operations team at Nucleix is responsible for advancing the company's pipeline of cancer diagnostic panels from concept to market. This includes overseeing the design, development, and optimization of new products, ensuring high-quality manufacturing and laboratory operations, managing international product logistics, and maintaining rigorous quality assurance standards.

Product Development and Operations

The Directorship Team at Nucleix is responsible for setting the strategic vision, overseeing the company’s operations, and ensuring alignment with overall business goals. This team of directors drives the development and commercialization of cutting-edge cancer diagnostic panels, manages key stakeholder relationships, and steers the company towards sustainable growth and innovation in the field of epigenetic biomarkers.

Directorship Team

Nucleix

Org chart

Board & advisors

Teams

Research and Development

Advisory Team

Leadership Team

Software and IT Team

Product Development and Operations

Directorship Team

Offices

Nucleix

Org chart

Board & advisors

Teams

Research and Development

Advisory Team

Leadership Team

Software and IT Team

Product Development and Operations

Directorship Team

Offices

Related companies